Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2026-05-15
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$2.7bn
reported value
+32.3% vs Q4 2025
33positions
72.1%in top 10
8 new
6 added
6 reduced
2 sold out
vs Q4 2025
Holdings, Q1 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $714.9m26.68% | Unchanged |
| ERASCA INC ERAS | $265.1m9.89% | Reduced -1.5m |
| ORUKA THERAPEUTICS INC ORKA | $203.5m7.60% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $185.9m6.94% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $130.3m4.86% | Reduced -254.5k |
| DIANTHUS THERAPEUTICS INC DNTH | $99.0m3.70% | Added +180.0k |
| DAMORA THERAPEUTICS INC COM NEW | $93.3m3.48% | New |
| OCULAR THERAPEUTIX INC OCUL | $87.6m3.27% | Added +3.0m |
| COGENT BIOSCIENCES INC COGT | $77.0m2.87% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $75.9m2.83% | Unchanged |
| SAVARA INC SVRA | $75.0m2.80% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $67.7m2.53% | Reduced -1.5m |
| ORIC PHARMACEUTICALS INC ORIC | $54.7m2.04% | Reduced -1.4m |
| VOR BIOPHARMA INC VOR | $54.3m2.03% | Added +1.1m |
| MAZE THERAPEUTICS INC MAZE | $47.8m1.78% | Added +53.5k |
| CYTOMX THERAPEUTICS INC CTMX | $46.9m1.75% | Reduced -5.6m |
| JADE BIOSCIENCES INC JBIO | $45.2m1.69% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $39.4m1.47% | Unchanged |
| CRESCENT BIOPHARMA INC. CBIO | $39.2m1.46% | Unchanged |
| ZURA BIO LTD ZURA | $38.3m1.43% | Added +1.1m |
| RELMADA THERAPEUTICS INC RLMD | $33.7m1.26% | New |
| ENGENE HOLDINGS INC COM | $32.5m1.21% | Unchanged |
| TENAX THERAPEUTICS INC TENX | $26.8m1.00% | New |
| ADLAI NORTYE LTD ANL | $22.2m0.83% | New |
| CENTURY THERAPEUTICS INC IPSC | $19.7m0.73% | New |
| CULLINAN THERAPEUTICS INC CGEM | $19.6m0.73% | Unchanged |
| CYBIN INC COM NEW | $18.5m0.69% | Added +11.4k |
| SURROZEN INC SRZN | $18.4m0.69% | Unchanged |
| SEPTERNA INC SEPN | $12.2m0.45% | Reduced -104.8k |
| KORRO BIO INC KRRO | $11.4m0.43% | New |
| ALTO NEUROSCIENCE INC ANRO | $11.2m0.42% | New |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $10.4m0.39% | Unchanged |
| X4 PHARMACEUTICALS INC XFOR | $1.4m0.05% | New |
Sold out since Q4 2025
| Security | Value then |
|---|---|
| UPSTREAM BIO INC UPB | $31.7m1.2m shares |
| CASI PHARMACEUTICALS INC CASIF | $839.2k987.3k shares |